Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s11675
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
SAGE Publications